Mechanism Pathway of Glucomannan as an Anti-inflammatory Agent in Carrageenan-Induced Rat Paw Edema
Document Type
Article
Publication Date
3-1-2026
Abstract
Background and objectives: Glucomannan is known for various therapeutic properties, including antidiabetic, anti-obesity, antihyperlipidemic, and anti-inflammatory effects. This study examined the anti-inflammatory mechanism of glucomannan in a carrageenan-induced rat paw edema model and compared its activity with indomethacin. Methods: Thirty male rats were divided into five groups: a carrageenan control group, an indomethacin group (10 mg/kg BW), and three glucomannan groups receiving 100, 200, or 400 mg/kg BW. Treatments were administered orally 30 minutes before carrageenan injection. Paw edema was assessed at baseline and at 1, 3, and 5 hours post-induction. Inflammatory markers were analyzed through immunohistochemistry for NF-κB, ELISA for IL-6 and TNF-α, and colorimetric assays for COX-1 and COX-2 activities. Results: Carrageenan produced a progressive increase in paw volume, while indomethacin markedly suppressed edema formation across all time points. Glucomannan also reduced paw edema in a dose-dependent manner, with the highest dose (400 mg/kg) approaching the efficacy of indomethacin. Biochemical and immunohistochemical analyses demonstrated significant downregulation of NF-κB, IL-6, TNF-α, COX-1, and COX-2 in the indomethacin and glucomannan groups compared with the control (p< 0.05). Histopathological evaluation of paw tissues revealed extensive inflammatory cell infiltration, vascular congestion, and tissue edema in the control group, whereas indomethacin and high-dose glucomannan showed markedly reduced. Conclusion: These results suggest that glucomannan exerts anti-inflammatory effects by inhibiting NF-κB activation and suppressing pro-inflammatory cytokines and cyclooxygenase pathways. Its efficacy, particularly at 400 mg/kg, demonstrates promising therapeutic potential comparable to indomethacin, supporting glucomannan as a potential natural anti-inflammatory candidate.
Keywords
anti-inflammatory, carrageenan, glucomannan, indomethacin, paw edema
Publication Title
Research Journal of Pharmacognosy
ISSN
2345-4458
DOI
10.22127/rjp.2026.557249.3024
Recommended Citation
Setiawati, Yuani; Sudjarwo, Sri Agus; Yuniarti, Wiwik Misaco; Mustafa, Mohd Rais; and Kurnijasanti, Rochmah, "Mechanism Pathway of Glucomannan as an Anti-inflammatory Agent in Carrageenan-Induced Rat Paw Edema" (2026). Research Publications (2026 to 2030). 1066.
https://knova.um.edu.my/research_publications_2026_2030/1066
Funders
Ministry of Higher Education, Science, and Technology of Republic Indonesia (114/E5/PG.02.00/PL/2023), Universitas Airlangga (1272/UN3, LPPM/PT.01.03/2023)
Volume
13
Issue
2
First Page
57
Last Page
66
Publisher
Iranian Society of Pharmacognosy